This issue is filled with great insights and expert commentary on areas that are relevant to the legal landscape and highlight how the business community is embracing technology, media and telecommunications. There are various topics covered, from new ways of working and digital transformation in the finance sector to data protection regulatory updates and guidance. We also have a series of articles that focus on e-commerce across a number of jurisdictions.
You will also find insights from our lawyers around real estate analytics, tech trends, and data centres.
We hope this edition of Law Update provides some useful food for thought – enjoy the read!Take a read of the edition
Effective 19 March 2020, the Saudi Food and Drug Authority (“SFDA”) issued a publication detailing that certain health products that were previously required to be “listed” at SFDA are now required to be “registered” as a health product in order to be marketed in Saudi Arabia. This update details these changes.
Health products classified as “subject for listing” are submitted to the SFDA under a simplified listing scheme. To classify a product as health product subject for listing, it must meet a series of criteria and/or be of a specific type of products.
SFDA has reclassified some of these types of products from being “subject for listing” to requiring “registration”, and changed the thresholds for registration in other instances.
This group of products includes the following:
Key SFDA guidelines for the registration of herbal and health products include:
The SFDA is responsible for putting in place regulations and effective controls to ensure the safety of food, drugs, medical devices, cosmetics, pesticides and feed in the Kingdom of Saudi Arabia. Please join our healthcare email list to receive more healthcare and life sciences legal and regulatory updates impacting the industry across the Middle East here.